EfficaSafe just got significantly smarter and more precise.
This upgrade adds a smart algorithm that integrates Pharmacodynamics (PD) and Pharmacokinetics (PK). It takes into account the strength of the evidence and the specific characteristics of the drug. Based on predefined clinical logic, the system prioritises what to show first, depending on whether the key mechanism is metabolic (like CYP3A4 inhibition) or clinical (like additive effects on blood pressure, coagulation, or the CNS), and presents the recommendation accordingly.
Key enhancements include:
• Full mapping of over 2,000 drugs by their major metabolising enzyme
• Prioritisation of strong clinical evidence even in the presence of moderate PK warnings
• Heightened sensitivity for NTI drugs and prodrugs
• A context-aware display that presents the most relevant data first
What does this mean for you?
• Improved accuracy of each interaction, integrating theoretical concerns and clinical data
• Clearer understanding of each interaction’s risk mechanism
• A further leap forward in patient care quality
EfficaSafe. Turning Interaction Complexity into Clinical Clarity
efficasafe.com/updates